Last reviewed · How we verify
Dexpanthenol foam spray, new formulation — Competitive Intelligence Brief
phase 2
Vitamin B5 derivative
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Dexpanthenol foam spray, new formulation (Dexpanthenol foam spray, new formulation) — Bayer. Dexpanthenol, a form of vitamin B5, helps to soothe and protect the skin by promoting the healing of wounds and reducing inflammation.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Dexpanthenol foam spray, new formulation TARGET | Dexpanthenol foam spray, new formulation | Bayer | phase 2 | Vitamin B5 derivative |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Vitamin B5 derivative class)
- Bayer · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Dexpanthenol foam spray, new formulation CI watch — RSS
- Dexpanthenol foam spray, new formulation CI watch — Atom
- Dexpanthenol foam spray, new formulation CI watch — JSON
- Dexpanthenol foam spray, new formulation alone — RSS
- Whole Vitamin B5 derivative class — RSS
Cite this brief
Drug Landscape (2026). Dexpanthenol foam spray, new formulation — Competitive Intelligence Brief. https://druglandscape.com/ci/dexpanthenol-foam-spray-new-formulation. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab